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ABSTRACT 
In this study 388 patients for induction of labour, 188 of 
favourable cervix induced by oxytocin, 200 patients of unfavourabl 
cervix induced by either intravaginal misoprostol of prostaglandins 
E2 (PGE2). 
The commonest indication for induction was prolonged 
pregnancy (70.6%), followed by PIH (17%) and then DM (8.2%). 
The average doses were 6.5 units for oxytocin, 59 µg for 
misoprostol and 3 mg for PGE2. 
The time of induction to delivery interval in the three methods 
misoprostol, oxytocin and PGE2 were 430 minutes, 499 minutes 
and 585 minutes, respectively. There were no significant 
differences between the three methods in the form of neonatal 
outcome or maternal complications. However, uterine 
hyperstimulation was more common in patients induced by 
misoprostol. 
The rate of C/S was 16%, no significant difference between 
the three methods in the C/S. 
Vaginal misoprostol was cheaper, stable at room temperature 
and more effective in labour induction than either PGE2 or 
oxytocin. 
  ﻤﻠﺨﺹ ﺍﻷﻁﺭﻭﺤﺔ
  
 ﻋﻨﻕ 881 ﻤﺭﻴﻀﺔ ﻤﻌﺩﺓ ﻟﺘﺤﺭﻴﺽ ﺍﻟﻭﻻﺩﺓ ﻤﻨﻬﺎ 883ﻋﻠﻰ ﺃﺠـﺭﻴﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ 
ﺍﻟﺭﺤﻡ ﻓﻴﻬﺎ ﻤﻭﺍﺘﻰ ﻟﻠﺘﺤﺭﻴﺽ، ﺇﺴﺘﻌﻤل ﻓﻴﻬﺎ ﻋﻘﺎﺭ ﺍﻜﺴﻭﺘﻭﺴﻴﻥ ﺒﻴﻨﻤﺎ ﻤﺎﺌﺘﻲ ﺤﺎﻟﺔ ﺃﺨﺭﻯ ﻋﻨﻕ 
 ﺃﻭ ﺒﺭﻭﺴﺘﻴﻥ ﺤﺒﻭﺏ  ﻤﻴﺯﻭﺒﺭﺴﺘﻭل ﺤﺒﻭﺏ ﻤﻬﺒﻠﻴﺔ-ﺍﻟﺭﺤﻡ ﻓﻴﻬﺎ ﻏﻴﺭ ﻤﻭﺍﺘﻰ ﺇﺴﺘﺨﺩﻡ ﻓﻴﻬﺎ ﻋﻘﺎﺭ
  . ﻤﻬﺒﻠﻴﺔ
ﻤﻥ ﺍﻷﺴﺒﺎﺏ ﺍﻟﺭﺌﻴﺴﻴﺔ ﺍﻟﺘىﺄﺩﺕ ﺇﻟﻰ ﺘﺤﺭﻴﺽ ﺍﻟﻭﻻﺩﺓ ﻓﻰ ﻫﺫﻩ ﺍﻟﻌﻴﻨﺔ ﻤﻥ ﺍﻟﻤﺭﻴﻀﺎﺕ 
ﻜﺎﻨﺕ ﻁﻭل ﻓﺘﺭﺓ ﺍﻟﺤﻤل ﻋﻥ ﺍﻟﻭﻗﺕ ﺍﻟﻤﺤﺩﺩ ﻟﻬﺎ، ﺇﺭﺘﻔﺎﻉ ﻀﻐﻁ ﺍﻟﺩﻡ ﺃﺜﻨﺎﺀ ﺍﻟﺤﻤل، ﺍﻹﺼﺎﺒﺔ ﺒﺩﺍﺀ 
  . ﺍﻟﺴﻜﺭﻯ
ﻓﻰ  ﻭﺤﺩﺓ ﺒﻴﻨﻤﺎ ﻜﺎﻥ ﻤﺘﻭﺴﻁ ﺍﻟﺠﺭﻋﺔ 5.6ﻜﺎﻥ ﻤﺘﻭﺴﻁ ﺍﻟﺠﺭﻋﺔ ﻓﻰ ﻋﻘﺎﺭ ﺍﻜﺴﺘﻭﺴﻴﻥ 
  .  ﻤﻠﺠﻡ ﻋﻠﻰ ﺍﻟﺘﻭﺍﻟﻰ3 ﻤﺎﻴﻜﺭﻭﺠﺭﺍﻡ، 95ﻋﻘﺎﺭ ﻤﻴﺯﻭﺒﺭﺴﺘﻭل ﻭﺒﺭﻭﺴﺘﻴﻥ 
ﺃﻗﺼﺭﻫﺎ ﻓﺘﺭﺓ ﺍﻟﻤﻴﺯﻭﺒﺭﺴﺘﻭل ﺍﻟﻔﺘﺭﺓ ﺍﻟﺯﻤﻨﻴﺔ ﺍﻟﺘﻰ ﺍﺴﺘﻐﺭﻗﻬﺎ ﺍﻟﺘﺤﺭﻴﺽ ﻜﺎﻨﺕ ﻜﺎﻵﺘﻰ 
  .  ﺩﻗﻴﻘﺔ ﺒﻭﺍﺴﻁﺔ ﺒﺭﻭﺴﺘﻴﻥ585 ﺩﻗﻴﻘﺔ ﻭﺁﺨﺭﻫﺎ 994 ﺩﻗﻴﻘﺔ، ﺘﻠﻴﻬﺎ ﺍﻜﺴﺘﻭﺴﻴﻥ034
 ﺍﻷﻡ ﺃﻭ ﺍﻟﺠﻨﻴﻥ، ﻤﺎ ﻋﺩﺍ ﺍﻟﺯﻴﺎﺩﺓ ﻻ ﻓﺭﻕ ﻴﺫﻜﺭ ﺒﻴﻥ ﺍﻟﻌﻘﺎﺭﺍﺕ ﺍﻟﺜﻼﺜﺔ ﻓﻰ ﺍﻟﻤﻀﺎﻋﻔﺎﺕ ﻋﻠﻰ
  %(. 5.9)ﻓﻰ ﺇﻨﻘﺒﺎﻀﺎﺕ ﺍﻟﺭﺤﻡ ﺍﻟﺘﻰ ﻻﺯﻤﺕ ﺍﻟﺘﺤﺭﻴﺽ ﺒﺎﻟﻤﺒﺯﻭﺒﺭﺴﺘﻭل 
ﻋﻘﺎﺭ ﻤﻴﺯﻭﺒﺭﺴﺘﻭل ﻴﻌﺘﺒﺭ ﻋﻘﺎﺭ ﻭﻫﻴﺩ ﺍﻟﺜﻤﻥ ﻭﻻ ﻴﺘﺄﺜﺭ ﺒﺩﺭﺠﺔ ﺤﺭﺍﺭﺓ ﺍﻟﻐﺭﻓﺔ ﻭﻫﻭ ﻋﻘﺎﺭ 
  .ﻓﻌﺎل ﻓﻰ ﺘﺤﺭﻴﺽ ﺍﻟﻭﻻﺩﺓ ﺃﻜﺜﺭ ﻤﻥ ﻋﻘﺎﺭﻱ ﺒﺭﻭﺴﺘﻴﻥ ﻭﺍﻜﺴﻭﺘﻭﺴﻴﻥ
          
 
 
 
 
LIST OF TABLES 
 Page  
Tables 1: The relationship between parity and indication of 
induction of labour                                    
 
38 
Tables 2: The average dose used in the three methods in 
the study population                                      
 
38 
Tables 3: Duration of induction of labour, comparison of the 
three methods                                       
 
39 
Tables 4: Comparison between three methods of induction 
in relation to the mode of delivery                        
 
39 
Tables 5: Indications of C/S in the three methods of 
induction of labour                                               
 
39 
Tables 6: Foetal outcome in relation to the antenatal foetal 
monitoring by B.P.P                                   
 
40 
Tables 7: Foetal outcome in relation to the antenatal foetal 
Monitoring by CTG                                   
 
41 
Tables 8: Foetal outcome from the total study population       41 
Tables 9: Comparison between foetal outcome in the three 
different methods                                    
 
42 
Tables 10: Comparison of maternal complications in three 
methods  
 
42 
Tables 11: The relation of the newborn's weight to the 
mode of delivery                                  
 
43 
Tables 12: Foetal outcome in relation of the newborn's 
weight       
 
44 
  
 
 
LIST OF FIGURES  
 Page  
Fig. 1:     Distribution of study population according to age     45 
Fig. 2a: Distribution of study population according to 
occupation                                       
 
46 
Fig. 2b:   Indications of induction in study population          47 
Fig. 3:    Average time of onset of efficient contractions in 
the different methods                         
 
48 
Fig. 4a: The first stage of labour in the three different 
method  
 
49 
Fig. 4b: The second and third stage of labour in the three 
different method                                   
 
50 
Fig. 5:   The mode of delivery among the study population     51 
Fig. 6: Distribution of the newborns weight in the stud group  52 
  
 
 
 
 
 
 
 
CONTENTS 
 
 Page No. 
Dedication              i 
Acknowledgment                        ii 
List of abbreviations                                 iii 
English abstract                                 iv 
Arabic abstract                                         v 
List of tables                               vi  
List of figures                             vii 
 
 
CHAPTER ONE 
Introduction  and Literature review                          1 
Objectives                             29 
CHAPTER TWO 
Patients & Methods                           30 
CHAPTER THREE 
Results                   34 
CHAPTER FOUR 
Discussion                   53 
Conclusion                   57 
Recommendations                  58 
References                    59 
Appendix (questionnaire) 
 
 
 1
INTRODUCTION AND LITERATURE REVIEW  
Definition: 
The intentional initiation of uterine contractions and cervical 
dilatation from 24 weeks with the aim of delivering the fetus vaginally 
before the spontaneous offset of labour. 
Incidence: 
The role of labour induction has been gradually increasing in 
the last decade due to early detection of foetal Jeopardy, improve of 
neonatal therapy and the availability of cervical ripening agents.(1) The 
incidence of induction varies, but in the UK it is in the order of                   
15 – 25%.(2) 
In the USA the incidence of induction is between 20-34%.(3) The 
Incidence of induction in the Sudan is unknown but in Soba University 
Hospital, the induction rate in the year 2000 was 4.3% and 6.67% in 
the year 2001. 
Historical development of labour induction: 
Accounts may be found in an ancient literature of techniques 
often extremely bizarre, whose purpose was to bring about the onset of 
labour. The first really effective intervention was artificial rupture of the 
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membranes or amniotomy, which was described in 1756 by Thomas 
Denman of the Middelsex Hospital, and came to be known as the 
(English method). Although it represented a major advance it was not 
without its complications, most notably if it did not lead to delivery 
within a relatively short space of time. The longer the interval between 
amniotomy and delivery the greater the likelihood of intrauterine 
infection. Because of this techniques were explored in the 9th and the 
early 20th century to avoid the need for amniotomy. Prominent among 
these was the use of various boogies or balloons, which were 
introduced through the cervix. Although the aim was to initiate uterine 
contractions, the biological impact was to provoke the release of 
endogenous prostaglandins although this has only been recognized 
within the last 30 years. Next in important was the discovery of 
oxytocin, which was widely accepted through the efforts of Turnbull 
and Anderson (1968) who advocated a policy of amniotomy followed 
by immediate intravenous titration of oxytocin. The later half of the 20th 
century has seen the biological role of prostaglandins.(4) 
Indications of induction: 
There are no absolute indications for induction of labour. 
However, termination of pregnancy is indicated when the fetus was in 
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greater danger in the uterus than it would be if delivered, or if the 
mother's life or health is endangered by the pregnancy continuing but, 
since the contributory factors are often multiple and rarely absolute, 
decisions are influenced by the nature and availability of resources in 
the delivery unit.(5) The spectrum of valid indications for induction of 
labour included emergency conditions, such as ruptured membranes 
with chorioaminitis or severe preeclampsia. There are also several 
relative indications. Indications of induction may be fetal or maternal. 
Fetal factors:  
Impaired placental function leads to fetal anoxia, the 
predisposing factors  include preeclampsia and others hypertensive 
disorders, maternal diabetes and sickle cell disease, general factors 
such as duration of pregnancy, maternal age and nutrition.(5) 
Prolonged pregnancy is a common indication of induction 
because the fetuses were noted to be at risk for hypoglycemia, thermal 
instability, and meconium aspiration. The small placentae lead to 
placental insufficiency, driving the fetus to use its own energy stores in 
the liver and adipose tissues. The result is a neonate with little 
subcutaneous fat and some degree of fetal weight restriction. Due to 
poor placental function, the amniotic fluid may be decreased, resulting 
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in increased risk of cord compression and passage of meconium. 
Uteroplacental insufficiency may result in non-reassuring foetal heart 
rate patterns even foetal death. So that induction of labour due to 
prolong pregnancy is undertaken 10-14 days after the expected date of 
delivery. Dates preferably confirmed by an early U/S will avoid 
unnecessary inductions for this indication. 
Rhesus or other erythrocyte antibodies may indicate the need of 
induction depending on the effect of the fetus and antibody titers, the 
time of induction depends on the facilities. 
Antepartum haemorrhage due to abruptio placentae commonly 
leads to induction of labour.(5)  
Other foetal factors, like malpresentation may be an indication 
for induction in circumstances like unstable lie. To do stabilization and 
induction reduces the hazards to mother and her baby. Also congenital 
malformation for example (Anencephaly) is regard as an indication for 
induction. IUFD is a common indication. 
Maternal factors: 
The maternal factors are uncommon with pregnancy 
complications such as preeclampsia and abruptio placentae, but foetal 
Consideration are usually dominant; planned delivery is desirable when 
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maternal disorders require carefully planned therapy or when 
spontaneous labour would cause additional hazard, e.g., diabetes 
Mellitus, nephritis, respiratory disease, infections, malignancies and 
certain autoimmune disorders.(5) 
Bist and colleagues (1999) in study of indications and obstetrics 
outcomes in tertiary referred hospitals found that the overall induction 
rate was 23%. The commonest indication is post-date (42%), diabetes 
mellitus (21%), PIH (12%), ruptured membranes (9%), foetal growth 
restriction (5%), and 4% due to chorioaminitis, the rest for non defined 
indications.(6) 
Brennand and Greer (1997) at Queen Mother's Hospital, 
Glasgow, found that indications of induction is 61.9% due to post term, 
11.4% due to PIH, 0.9% oligohydramonas, while 0.5% were due to 
diabetes mellitus and other conditions (12.4%).(7) 
Contraindications to induction: 
A number of uterine, fetal or maternal conditions present 
contraindication to labour induction. Most of these are similar to those 
that would preclude spontaneous labor and delivery. Uterine 
contraindications primarily relate to a prior disruption such as a 
classical incision of uterine surgery or hysterotomy or full thickness 
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myomectomy. Placenta praevia would also preclude labour. Foetal 
contraindications include macrosomia, some fetal anomalies such as 
hydrocephalus, mal-presentations, or non-reassuring foetal status. 
Maternal contraindications are related to contracted pelvis, and 
selected medical conditions such as active genital herpes pelvic 
tumor.(3) 
Assessment of the patients for induction: 
Before the beginning of induction we must assess the patient by 
gestational age, the menstrual dates and cycle should be checked 
together with any other available evidence, such as ultrasound, 
radiology and foetal lung maturity may be assessed by the amniotic 
fluid lecithin/sphingomyelin ratio to check is there any contraindication 
of induction.(5)  
The condition or "favorability" of the cervix is important for 
labour induction, in many cases, the induction technique chosen 
depends upon the perceived ease of it's anticipated success. 
Physical characteristics of the cervix and lower uterine segment 
are most important. The level of the presenting part or station is also 
important. One quantifiable method that is predictive of a successful 
labour induction is that described by Bishop (1964). Elements of the 
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Bishop score include dilatation, effacement, station, consistence, and 
position of the cervix (Table 1-1). 
Table1-1: Bishop scoring system used for assessment of inducibility 
Score Dilatation (cm) Effacement (%) Station Cervical 
consistency  
Cervical 
position 
0 Closed 0 - 30 -3 Firm Posterior 
1 1 -2 40 - 50 -2 Medium Mid-position 
2 3 – 4 60 – 70 -1 Soft Anterior 
3 ≥ 5 ≥ 80 +1, +2 — — 
Induction to active labour is usually successful with a score of 9 
or greater and less successful with lower scores. Most practitioners 
would consider a women whose cervix is 2cm dilated, 80% effaced, 
soft and mid-position, and with the fetal occiput at -1 station as likely to 
have a successful labour induction. In these circumstances, initiation of 
labor with a dilute intravenous oxytocin solution is usually successful. 
As the Bishop score decreases, with unripe cervix, these are an 
increasingly unsuccessful induction rate. This research has been 
directed toward various techniques to "ripen" the cervix prior to 
stimulation of uterine contractions.(8) The onset of human parturition 
does not fit into many of the animal models used. It is thought that the 
mechanism may depend on an interaction between the contiguous 
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tissues of the fetus and mother, namely the chorion (both membranes 
and placenta) and the decidua. 
The action of prostaglandins in initiating labour is partly by 
stimulation contractions, but probably mainly by ripening and 
increasing the sensitivity of the cervix to oxytocin.(2)  
Physiology of labour: 
Labour is defined as the progressive dilatation of the cervix in 
association with repetitive, strong uterine contractions. The factors that 
initiate and promote labour are complex and not well understood. 
Oxytocin receptors in the uterus increase 100 fold by 32 week 
gestation and 300 fold at parturition. Although important for the actual 
labour process, this increased sensitivity to oxytocin only minimally 
predicts the duration of labour, which is more affected by parity and 
cervical status at the onset of labour. Cervical ripening (the softening, 
effacement and dilatation that occur before active labour is mediated 
by multiple factors (PGE2, PGF2-α) appear to be the final mediators in 
this process, although the exact mechanism is unknown. 
Endogenous oxytocin is the main stimulator of uterine 
contractions. It also stimulate the production of PGE2 and PGF2-α and 
these may stimulate myometrial contractility.(9) 
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Methods of induction of labour: 
These can be divided into medical (prostaglandins and 
oxytocin) and mechanical methods (amniotomy, membrane sweep, 
hygroscopic tents or dilators). Other medical and mechanical methods 
exist but are not commonly used, the choice depends on the state of 
the cervix as determined by Bishop score and the obstetric history. 
Amniotomy is the corner stone of any method of induction.(1) 
Amniotomy: 
Amniotomy or artificial rupture of the membranes, also referred 
to as surgical induction, is commonly used to induce or augment 
labour. The main disadvantage of amniotomy when used alone for 
induction is long interval to the onset of contractions. In randomized 
trial  Bakos and Backstrom (1987) found that amniotomy alone or 
combined to oxytocin was superior to oxytocin alone, Mercer and 
colleagues (1995), found that early amniotomy at 1-2 cm dilatation was 
associated with significant shorter labour four hours but there was 
increased. Incidence of chorioaminitis and cord compression.(3) 
Amniotomy and release of the amniotic fluid is the most efficient 
mechanical method of inducing labour. The way in which this is 
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mediated by separation of membranes results in prostaglandins 
release and this may encourage uterine activity.(10) 
Low amniotomy: 
A forewater rupture is easily performed by inserting the fingers 
and ruptured the membranes with a sharp pointed instrument 
(Goodwins Forceps, Amnihook) or with a Kocher forceps. Hind water 
rupture is achieved by introducing a specially designed (Drew-Smythe) 
catheter between the membranes and the uterine to a point above the 
presenting part, it is not used routinely in practice due to the hazard of 
trauma to the uterus, and separation of the placenta, Amniotomy alone 
results in delivery with 24 hours in about two-third of cases.(5) 
Disruption of the chorioamnion likely results in arachidonic acid 
conversion by the cyclooxygenase pathway to PGE2, resulting in 
increased uterine activity. In addition, reducing the intrauterine volume 
by allowing egress of amniotic fluid may allow an increase in contractile 
strength. It is a highly successful means when used in conjunction with 
the other methods of labour induction. The indications for amniotomy 
other than induction inability to monitor the foetal heart rate with 
external means, the need to evaluate the amniotic fluid, the need to 
administer an amnion infusion; the contraindications: placentae 
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praevia, vasapraevia abnormal foetal lie, prior classical caesarean 
incision, or active herpes simplex virus infection. In general amniotomy 
should be avoided in patients with an unengaged presenting part, this 
will increase the risk of umbilical cord prolapse.(11) 
Oxytocin: 
Oxytocin is a polypeptide hormone, which first became widely 
used for induction of labour in 1955. This was relatively impure and 
had varying degrees of vasopressor and antidiuretic activity as well as 
occasionally in pure form and produce for fewer secondary effects. 
Although oxytocin is not in itself responsible for the onset of 
spontaneous labour it is extremely effective in inducing uterine activity.   
It's mode of action is to depolarize cell membrane potential and other 
permeability to sodium. Osterogen and progesterone increase 
membrane potential and can therefore, inhibit the action of oxytocin. In 
late pregnancy oxytocin increases the frequency and amplitude of 
contractions, thus potentiating an already existing contraction pattern.   
Maximal sensitivity to oxytocin is achieved by 34-36 weeks gestation.(5) 
Oxytocin should be used for induction following ARM of 
favourable cervix. It should only be started if the membranes have 
been ruptured. CTG monitoring is mandatory.(12) 
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Oxytocin is a hormone that contains eight amino acids and is 
produced by the posterior pituitary gland. In the circulation it has an 
effective half-life 5-10 minutes, pharmacological preparations are 
available for administration by buccal, intranasal, intramuscular or 
intravenous route.  It acts by increasing free intracellular calcium and 
stimulate uterine contractions. The route of administration is by infusion 
because of the potential side effects of excessive uterine activity and 
systemic hypotension. The dose is 1-2 mU/min, with subsequent 
increases of 1-2 mU/min every 30 minutes until the desirable 
contractile pattern is reached. Although higher starting doses and more 
rapid increase in infusion rate have resulted in shorter duration of 
labour, however, it is associated with, high incidence of uterine 
hyperstimulations.  There is still some debate about the optimal dosing 
regimen of oxytocin for maximal effectiveness and minimal untoward 
effects.  
Kelly, et al (2001) in study of intravenous oxytocin and induction 
of labour found that, vaginal delivery is 89.6%, C/S (10.4%), using 
average dose (10 units), the time of induction to delivery 340 
minutes.(13)Studies show a wide range of effective dosage and changes 
intervals, and no regimen has been shown to be clearly superior.(14) 
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Side effects: 
The side effects of oxytocin can be extremely serious. 
Excessive doses can cause uterine hyper-stimulation, which may 
cause fetal hypoxia and uterine rupture. High doses of oxytocin may 
have an antidiuretic effect that results in significant fluid retention and 
overload with prolonged administration.(11) 
Special supervision and  precautions are required in multiparae 
who tend to be more sensitive to oxytocin; when the uterus is scarred   
from caesarean section, hystrotomy, myomectomy scar or following 
cone biopsy of the cervix; when dispropotion is suspected; or when 
fluid over load may be particularly hazardous as in cardiac disease.(5)  
Oxytocin titration for induction of labour: the study show that, 
the oxytocin doses was" escalated every 15 min in the first group whilst 
for the second group the dose was increased every 30 min till optimal 
uterine activity was achieved, there was no significant difference in the 
mean maximum dose of oxytocin and length of labour in the two 
groups.(14) 
For the induction of labour in women of high parity the infusion 
rate of oxytocin should be increased every 45 minutes rather than 
every 15 minutes until contractions occur three times in 10 minutes and 
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this infusion rate of oxytocin is maintained until delivery, this reduces 
the complications of labour and delivery but increase the time of 
induction by means 2 hours.(15) 
Oxytocin receptor undergoes desensitization after prolonged or 
repeated stimulation. The concentration of myometrial oxytocin 
receptors and the steady state of its mRNA were measured in patients 
477 (175-641) FMOL mg (-1) protein and decreased to 140(72-206) 
FMOL mg (-1) protein during prolonged oxytocin-augmented and 
oxytocin-induced labour, respectively. The corresponding   oxytocin   
receptors mRNA concentrations decreased by 60-300 fold, 
respectively. The decrease in receptor binding and mRNA in women 
receiving oxytocin infusion indicates that homologous receptor 
desensitization occurs in vivo.(16) 
Prostaglandins: 
These are long-chain unsaturated fatty acids containing a five 
carbon ring along their length, derivatives of a hypothetical molecule, 
"prostanoic acid". They are found in most tissues and in especially high 
concentration in seminal vesicles. There are four major groups of 
naturally occurring prostaglandins, E, F, A and B. Some prostaglandins 
and a number of chemical derivatives have been synthesized. The 
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compounds of most importance in obstetric practice are prostaglandins 
E1, E2 and F2-α. Other derivatives must be regarded as still under 
evaluation.(17) 
Prostaglandins clearly play role in the initiation of the normal 
labour process in humans. One of the key processes linked to 
prostaglandins is an alteration in the collagen matrix and water content 
of the cervix. These changes result in softening and effacement, a 
process referred to as ripening. Artificial ripening of the cervix is a 
method used commonly in preparation for labour induction in 
parturients whose cervix has not yet undergone natural ripening. 
Success of labour induction is initiated with a ripened cervix in contrast 
to an unripened cervix. Artificial cervical ripening can be accomplished 
through the use of exogenous prostaglandin preparations applied to 
the cervix or by promoting local endogenous prostaglandins production 
by mechanically disrupting the interface between the foetal membranes 
and the upper cervix. Methods commonly used to increase local 
prostaglandin production include placement of mechanical dilators into 
cervical canal, digital sweeping of the membranes away from the cervix 
or placement of a Foley's catheter through the cervical canal and 
instilling crystalloid solution through the catheter to elevate the foetal 
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membrane away from the cervix and lower uterine segment. These 
methods cause release of arachidonic acid from the fetal membranes 
with subsequent endogenous prostaglandins production. 
Exogenous PGE2 preparation is commonly used for initiations 
of local cervical ripening and induction of labour. 
Important prerequisites for the use of PGE2 preparations are the 
ability to monitor uterine activity and foetal heart rate. After 
administration, the patient remains recumbent for 1 hour and remain 
under monitoring of uterine activity and fetal heartbeat for at least 2 
hours.(11) 
Route of administration and preparations of prostaglandins 
Local application of prostaglandins of prostaglandin E2 gel 
(Dinoprostone) is widely used with intracervical or intravaginal. The gel 
is available in a 2.5 ml syringe that contain 0.5 mg of dinoproston. The 
intracervical route offers the advantages of prompting less uterine 
activity and greater efficacy in women with a very unripe cervix. 
Prostaglandins E2 vaginal tabs various dosage of intracervical 
(0.3-0.5 mg) or intravaginal (3-5mg) high into posterior fornix with the 
second dose 6-8 hours if the labour not established. Maximum dose is 
6 mg. A 10 mg dinoprostone vaginal insert (cervidil) also was approved 
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1995 for cervical ripening. The insert provides slower release of 
medication (0.3 mg/hr) than the gel. The advantage of the insert can be 
removed if hyperstimulation occur.(18) 
Prostaglandin gel inserted into the posterior fornix, primigravida 
2mg gel and multiparae 1 mg gel, if there is no uterine activity after 6 
hours give further dose. The maximum quoted dose is 4 mg in 
primigravidae and 3 mg in multiparae.(12) 
Prostaglandins increase the frequency and amplitude of uterine 
contractions, possibly by promoting oxytocin release from posterior 
pituitary but more likely by sensitizing myometrial cells to oxytocin. 
PGE2 is 5-10 times more effective in stimulating uterine activity than 
the other major oxytoxic PGF2-α. 
Intravenous administration: 
I.V. PGE2 are very effective given at initial dosage of 0.25 
µg/min, but have unpleasant side effects particularly gastrointestinal 
symptoms and local inflammatory reactions. 
Oral tablets: 
Oral tablets has advantage of convenience to patient, but the 
side effects usually prove to be unacceptable, before adequate 
therapeutic effect has been achieved, the side effect usually is less 
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than when PGE2 is used. The dose is 0.5 mg hourly initially rising up to 
2 mg hourly. 
Local administration: 
Various   modes of local administrations, including intraaminotic 
injection, extraaminotic infusion, gel and pessaries. For most 
obstetrical purpose local application of PG is preferred because of the 
effectiveness and minimal side effects.(5) 
Side effects of PGE2: 
Hyperstimulation can occur, which cause fetal asphyxia and 
may lead to ruptured uterus. Gastrointestinal symptoms are 1% in local 
administration but more in systemic, and it may cause fever.(3) 
Other side effects: nausea, vomiting, diarrhoea, muscle 
weakness, dizziness, dyspnoea, chest pain, mild pyrexia, headache 
and peripheral flushing due to vasodilatation are relatively uncommon 
with vaginal or intrauterine administration. 
Special features: 
The pessaries are easy to use; the gel allows flexibility of dose 
and provide more rapid absorption. Pessaries or gels should be stored 
at 4°C. Prostaglandins have no antidiuretic effect so can be used on 
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patient with cardiac disease or severe pre-eclampsia. They are active 
on the uterus at any stage of pregnancy if sufficient dose is used.(17) 
The prostaglandins have been found to produce the best results 
for inducing labour when the cervix is unripe and are most effective 
when administered locally and most convenient when placed in the 
vagina as a viscous gel, wax pessary or slow release pessary. They 
are of benefit for labour induction in cases previously delivered by 
lower segment caesarean section, breech presentation and multiple 
pregnancies hyperstimulation and foetal distress may occur and this 
might be reduced with the use of the controlled release hydrogel 
pessary.(19) 
Kelly, Kavanagh, et al (1999) in study of vaginal prostaglandins 
(PGE2 and PGF2-α) for induction of labour at term found that, achieved 
vaginal delivery with 24 hours by 82% versus 1% placebo or no 
treatment. The C/S were not different between groups, although the 
risk of uterine hyperstimulation with foetal heart changes is 4.6% and 
risk of oxytocin augmentation reduced (53.9%).(20) 
Bahar and colleagues at Abha Maternity Hospital found that, 
the low dose regimen of 1.5 mg is as effective as the high dose    
regimen of 3 mg PGE2 vaginal tablets in inducing labour. No difference 
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in induction-delivery interval, C/S rate and Apgar score. They found 
that C/S rate depends only on maternal age and Bishop score rather 
than on parity and gestational age.(21) 
Misoprostol: 
A new synthetic prostaglandin that is achieving wide 
acceptance for labour induction, it is a synthetic, methylated PGE1 
analog originally developed to treat gastrointestinal ulcers; misoprostol 
has been shown to have improved efficacy to that of PGE2 in the 
aspects of safety, successful induction and side effect profile. It is 
currently administered intravaginally or orally. The intravaginal dose 
range from 25-100 µg every 4 - 5 hours. Misoprostol is a potent agent, 
and it is major side effects noted is an increase in the incidence of 
tachysystole, which is usually defined as the occurrence of more than 
six contractions in a 10 minute time period. It differs from uterine 
hyperstimulation in that it is not associated with fetal heart rate 
abnormalities and typically required no treatment. No significant 
differences between misoprostol and PGE2 in the incidence of 
caesarean section, maternal side effects or neonatal outcome. The 
optimal dosage and dosing interval have yet to be completely 
determined.(11) 
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Route of administrative doses: 
Vaginal misoprostol: 
Initial studies suggested that misoprostol tablets placed into the 
vagina were either superior to or equivalent in efficacy compared with 
intracervical prostaglandins E2 gel. The dose of intravaginal misoprostol 
in an approximate 25 µg, such usage is considered to decrease the 
need for oxytocin, achieve higher rates of vaginal delivery within 24 
hours of induction, and significantly reduce induction-to-delivery 
intervals.(22) The 50µg dose result in significantly increased 
tachysystole, meconium passage and meconium aspiration compared 
with prostaglandin E2 gel. This will also increase incidence of 
caesarean delivery due to uterine hyperstimulation when compared 
with dinoprostone. The 25 µg dose every 3 hours was associated with 
significantly fewer adverse effects than the 50µg dose.(23) In one report, 
Plaut and associates (1999) described uterine rupture in 5 of 89 (6%) 
women with a previous caesarean delivery who were induced with 
misoprostol compared only 1 of 423 such women not given 
misoprostol.(24) 
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Oral misoprostol: 
Windrim and associates (1997) reported that orally 
administered misoprostol was of similar efficacy for cervical ripening 
and labour induction as intravaginal administration. Bennett and 
colleagues and Toppozada and co-workers (1997) found a shorter 
interval-to-delivery with the vaginal application, but more frequent 
foetal heart rate abnormalities. Adair and colleagues (1998) conclude 
that oral and vaginal applications were of similar efficacy but that an 
oral dosage of 200 µg was associated with more frequent abnormal 
uterine contractility. Wing and collaborators (1999) reported that 50 µg 
oral misoprostol was less effective than 25 µg administered vaginally 
for cervical ripening and labour induction. These investigators (Wind 
and colleagues, 2000) subsequently reported that a 100 µg oral dose 
was as effective as the 25 µg intravaginal dose.(22) 
Advantages of misoprostol: 
It is cheap in price one $ by one tablet, can be stable at room 
temperature no need for refrigeration. Misoprostol is useful in the 
management of elective medical and surgical abortion, miscarriage, 
and postpartum haemorrhage.(25) 
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Misoprostol is more effective drug in labour induction than 
dinoprostone. 200 µg of misoprostol intravaginal tablets compared with 
3 mg of dinoprostone, the study show that in the misoprostol group 
labour was successfully established in 92% of cases compared with 
64% in dinoprotone group. Maternal and neonatal complications, mode 
of delivery, the need for oxytocin and pethidine were quite similar 
statistically but polysystole is more frequent in misoprostol.(26)Fifty µg of 
sublingual misoprostol every four hours has the same efficacy and 
safety profile as compared with 100 µg orally, but the oral route might 
be preferred by women.(27) 
Mjoko, Zeizawi (2002) in study of vaginal misoprostol for 
induction of labour found that, the need for augmentation with oxytocin 
is significantly in mode of delivery. There was a significantly reduced 
risk of C/S for failure of progress in the vaginal misoprostol, vaginal 
misoprostol significantly shortened time interval from induction to 
delivery, there were more admission to neonatal units in the 
misoprostol group.(28) 
Sanches and others (1995) found that the use of misoprostol 
was associated with a higher incidence of tachysystolic but not 
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hyperstimulation, and the mean interval from "start of induction to 
delivery was 4.6 hours.(29) 
Mechanical methods of induction of labour (Surgical): 
Balloon Catheter: 
Was first attributed to Barnes by Woodman (1863) for dilation of 
the cervix. Several variations of this method are used currently. One 
method includes the infusion of extra-amniotic normal saline and is 
referred to by some as EASI. Sherman and colleagues (1996) 
summarized the results of balloon catheter with or without saline 
infusion concluded that, the method resulted in rapid improvement of 
Bishop Scores and shorter labours.(30) Schreyer and colleagues (1989) 
found that extra-amniotic saline infusion resulted in greater increase in 
Bishop Score in less time than vaginal prostaglandins E2.(31) Vengalil 
and colleagues (1998) reported similar outcomes with caesarean 
delivery rates and induction-to-delivery times with catheter infusion 
compared with 50µg misoprostol administered vaginally every 4 
hours.(32) Hemlin and Moller (1998) reported that balloon catheter is 
effective in ripening of the cervix more than intracervical PGE2.(3) 
In randomized prospective study April 1992, the study was to 
compare the efficacy and to variability of three methods of cervical 
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ripening in patients at term for induction of labour with unfavourable 
cervix (Bishop Score less than 6). In the first group patient received an 
intracervical instillation of PGE2. Second group, an intracervical Foley's 
catheter with it is balloon inflated to 50 cc of sterile water. The third 
group extraamniotic injection of PGE2 via a Foley's catheter. These 
results show the superior efficacy of the catheter plus PGE compared 
with other two methods; as well as that intracervical catheter is equally 
effective in terms of success and failure as a catheter alone.(33) 
Hygroscopic cervical dilators: 
One or more hygroscopic dilators can be inserted into the cervix 
and produce softening and dilatation through expansion by absorbing 
fluid. Improvement of the Bishop Score takes from four to eight hours 
after insertion.(1)  Cuinn and co-workers (2000) reported that cervical 
ripening with cervical dilators plus oxytocin induction were similar in 
efficacy to either catheter infusion or prostaglandin E2, cervical gel. It is 
of some benefit for initiation of cervical dilation, the attraction of these 
dilators is their low cost, ease of placement, and their ability to be 
quickly removed.(34) 
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Sweeping the membranes: 
Membrane sweeping or stripping is an old method of inducing 
labour that is still in common use. This intervention results in a local 
increase in prostaglandin production and to hasten the onset of labour. 
The intervention had no significant impact on mode of delivery or the 
incidence of maternal or neonatal infections but it is painful to the 
women.(35) 
Other methods of induction of labour: 
1. Electrical stimulation of the myometrium. 
2. Administration of corticosteroid. 
These techniques do not result in immediate onset of labour but 
may be of value in increasing myometrial sensitivity to oxytocin or may 
hasten the onset of labour in prolonged pregnancy.(5) 
Comparative studies between different methods of 
labour induction: 
Kadanali et al (2000) in their study to compare the efficacy and 
safety of intravaginal and oral misoprostol vs. oxytocin/PGE2 for third 
trimester labour induction, the results, induction to active phase of 
labour was successfully achieved 85.7% in misoprostol group vs. 
76.8% in the oxytocin /PGE2 group, but the drug initiation delivery 
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interval was significantly shorter in the misoprostol (9.2 ± 2.4 hrs.) than 
in the oxytocin/ PGE2 group (15.2 ± 3.2 hrs.), the incidence of adverse 
intrapartum outcomes was similar for both methods. There was a 
higher prevalence of C/S for failed induction in the oxytocin/ PGE2 
group than in the misoprostol   (13.4% vs. 6.3%) the neonatal outcome 
of both groups were also similar.(36) 
In comparative study of misoprostol with oxytocin, they found 
that latent period per minutes and time of induction to vaginal delivery 
(hours). Misoprostol 252.9 min (latent period), interval from induction to 
delivery (10.6 hrs). Oxytocin 352.3 min (latent period), interval from 
induction to delivery (14.8 hrs).The dose of misoprostol is 25 µg, while 
the dose of oxytocin is maximum 20 mU/min. Vaginal delivery 
misoprostol 81%, 64% in oxytocin.(37) 
Hazards of induction of labour: 
Induction of labour while potentially of great benefit may also 
bring complications. Amniotomy exposes the fetus to the risk of 
intrauterine infection, especially if delivery is delayed and may also 
result in prolapse of the umbilical cord.(4) High dose of oxytocin infusion 
and diluted solutions may cause fluid retention, pulmonary oedema, 
electrolyte imbalance, coma and death. Hyperstimulation of the uterus 
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may lead to fetal distress or ruptured uterus. Placental abruption 
particularly following an uncontrolled   amniotomy with polyhydramnios. 
Following prolonged induction may result in uterine exhaustion and 
atonia which cause postpartum haemorrhage.(1) It is also likely that the 
increase   in caesarean deliveries associated with labour induction.(3) 
Boulvai and others (2001) found that when evaluate the risks of 
maternal and perinatal morbidity associated with induction of labour, 
high risk of C/S, use of epidural analgesia was more frequent, 
resuscitation and admission to the intensive care unit were more 
frequent.(38) 
Hofmeyer (2001) found that induction of labour using 
misoprostol overall C/S rates appear to be reduced, despite a relative 
increase in C/S for fetal heart rate abnormalities. Concern remains 
regarding increase rates of uterine hyperstimulation and meconium 
stained amniotic fluid, increase PPH, and isolated report of uterine 
rupture.(39) 
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OBJECTIVES 
 
• To study the different methods used in practice of labour induction in   
teaching hospitals as their effectiveness and safety. 
1- Oxytocin plus artificial rupture of membranes. 
2- Prostaglandins: 
a. PGE2. 
b Misoprostol. 
 
• Effectiveness to be assessed by: 
a. Duration of induction. 
b. Failure rate leading to caesarean section. 
• Safety to be assessed by degree of maternal and foetal 
complications. 
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PATIENTS AND METHODS 
Study design and duration: 
A hospital-based prospective study conducted in June 2002 to 
July 2003. 
Study area: 
This study was conducted in the Omdurman Military Hospital, 
Omdurman Maternity Hospital, Suba University Hospital and Elsaudi 
Hospital. 
Study population: 
Patients planned, or for emergency induction attending the 
above mentioned hospitals. 
Inclusion criteria: 
The choice of the cases depends on the following: single 
pregnancy, viable, term, cephalic, no uterine scar before, no placenta 
praevia and the parity not more than four, estimated foetal weight not 
more than 4 kg. Reactive CTG and B.P.P to be accepted to whom the 
investigations was done.           
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Exclusion criteria: 
Estimated foetal weight greater than 4,000 g or evidence of  
cephalopelvic  disproportion; placenta praevia or any unexplained 
vaginal bleeding, foetal malformation, previous uterine scar, any 
situation when vaginal delivery was not indicated and any 
contraindication of use of prostaglandins or oxytocin (heart defect, 
glaucoma,  increased intraocular pressure, bronchial (asthma). 
Investigations:                                    
General investigation e.g. Mb, urine general analysis and 
specific investigations, mainly for the foetal wellbeing cardiotocography 
and biophysical profile, but this had not been done in all patients, 
because of the lack of resources. 
Questionnaire: 
Information on age, parity, mode of previous deliveries, 
indication of induction and detailed about assessment obstetrical 
examination especially the favourability of the cervix, which determine 
the choice of the method of induction, the result of the induction to the 
mother and her baby. 
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Methods of induction: 
The choice of the method depends on the condition of the 
cervix, favourable or not, in case of favoutable cervix infusion ocytocin 
was titrated and the starting dose varies according to the parity in 
primigravida, we start with 2 units and increase the rate and 
concentration until we reach the efficient contractions, however, if the 
patient is multipara the starting dose is one unit. Amniotomy was 
carried out when cervical dilatation is four centimeter or more. 
Monitoring of foetal heart rate every 15 minute using either Penard 
stethoscope or sonicaid for hearing the foetal  heart and calculating the 
rate after the start of the contractions. 
In case of an unfavourable cervix we use either misoprostol or 
prostin. For women receiving misoprostol 50 µg were administered in 
the posterior fornix of the vagina. If there are no contractions the dose 
was repeated after 4 - 6 hours until reach four doses maximum dose 
200 µg. If the onset of contraction occurs but not three contractions or 
more per ten minutes, infusion oxytocin and amniotomy was to be 
done. 
The other group of unfavourable cervix, which randomly 
selected 3 mg of prostin (PGE2) was inserted in the posterior fornix of 
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the vagina after four hours if there is no contraction another dose was 
to be repeated. If the contractions not efficient oxytocin and amniotomy 
to be done. 
Close follow up specially by foetal heart monitoring, and 
intrapartum uterine activity was performed. If hyperstimulation of the 
uterus present, the following measures were taken: 
• Prostaglandins preparation were washed out from the vagina. 
• Oxytocin infusion was abandoned, because of unavailability of 
uterine relaxant if hyperstimulation dose not stopped the patient 
will be prepared for surgical intervention by caesarean section. 
Data analysis: 
For data analysis, the comparability of the groups was initially 
evaluated through the variable distributions. 
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RESULTS 
Three hundred eighty-eight pregnant women were induced by 
different methods, 188 were allocated to use oxytocin, 168 to use 
misoprostol, and 32 used prostin. In order to demonstrate the  
randomization process for the groups, the results were presented. 
Demographic characteristic of women in the study: 
Age: 
The age of the pregnant women in the study was between 17-
40 years. However, the majority of women 354 (92%) were between 
17-34 years. The distribution of study population according to age is 
shown in (Fig.1). 
Origin and occupation: 
The women in the study were from different areas in the capital 
Khartoum and ground it. The majority of women in the study (89.2%) 
were housewives and 10.8% were employee.  
One hundred fifty-six of the patients (40%) were primigravida, 
232 were multiparae (60%), most multiparae had smooth previous 
vaginal deliveries, and only 16 patients (6.7%) had been induced 
before (Fig. 2a). Prolonged pregnancy was the commonest indication 
of induction of labour followed by PIH, DM (Fig. 2b). 
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The majority of the primigravidae induced, because they had 
prolonged pregnancy, PIH and DM. However, in multiparae but in 
different percentage (Table 1). 
The dose of misoprostol was 50 µg if there is no contractions 
another dose should be administered after four hours. The mean dose 
is 59ug. In inefficient contractions oxytocin should be given,  29(17.3%) 
of the pregnant women induced by  misoprostol received oxytocin,        
3 mg vaginal tablets were used of PGE2 as a single dose, no added 
dose was administered, but 8(25%) of the women induced by PGE2 
needed additional acceleration by oxytocin to have efficient 
contractions. The average dose of oxytocin was 6.5 units (Table 2). 
The average time of the onset of efficient contractions from the 
beginning of induction in the different methods (Fig. 3). 
The first stage of labour in misoprostol, oxytocin, PGE2  was 414 
min, 456 min, 559 min respectively, the second stage was 12 min, 33 
min, 19 min respectively, the third stage was 4 min, 10 min and 7 min 
respectively (Fig. 4a, b). 
The duration of induction in the three methods (misoprostol,  
oxytocin and PGE2) were 430 min, 599 min, 585 min respectively 
(Table 3). 
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Mode of delivery: there was no significant different in mode of 
delivery of the three methods. 
The overall failure rate of induction of labour in all the three 
methods end in C/S was 16%, instrumental delivery about 3% and 
81% vaginal delivery (Fig. 5). 
Table 4 shows the mode of delivery according to the different 
methods. 
Indications of C/S in the different methods showed significant 
difference in uterine hyperstimulation, which was the commonest 
indications of C/S in misoprostol, however, failure of progress was the 
commonest in both PGE2 and oxytocin (Table 5). 
Foetal assessment: 
Foetal assessment before induction was essential, but lack of 
facilities prevent the assessment, so is the majority of the pregnant 
women in the study, no CTG done to 79.6% of women in the study 
population, all the cases of the study, which CTG had done to, had 
reactive CTG. Biophysical profile had been done to 23(5.9%), not done 
to 365(94.1%). The minimal score for induction in the study of B.P.P 
was 6/8, this should include adequate liquor (Tables 6 and 7). 
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Foetal outcome from the total study population (Table 8). Foetal 
outcome from three different methods show no significant difference of 
foetal outcome (Table 9). 
The three different methods only differ on the complication of 
uterine hyperstimulation, which was 9.5% of the women induced by 
misoprostol and zero percent to other two groups of PGE2 and 
oxytocin. In other complications there was no significant difference in 
the three methods of induction (Table 10). 
Foetal weight: 
The majority of the foetal weight (81.7%) were located between 
the range of 2.6 - 3.5 kg. The weight which was > 4 kg should not be 
included in the study, but this appeared due to wrong estimation of 
foetal weight, 4 cases (1%), they end in 50% C/S and 50% 
instrumental delivery. The weight, which was below normal (2-2.5 kg) 
were (3.3%) had result of 7.7% fresh stillbirth (Fig. 6). 
There was no significant difference in mode of delivery and 
foetal outcome in the study group in relation to weight (Tables             
11 and 12). 
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DISCUSSION 
Post-maturity is the commonest indications of labour induction 
worldwide.(5) In this study the majority of pregnant women were 
induced due to prolonged pregnancy too (70.6%).       
In other study(6) the percentage of post date is 44%, in this 
study is 70.6%, this difference may be due to the patient behaviour to 
the induction of labour in the other communities. 
In previous studies the optimal dose of oxytocin was between    
1-2 mU/min, this was calculated by automated machine. However, the 
dose in this study was almost always the same even it was calculated 
by drops and concentrations. 
In the literature the oxytocin was titrated by increasing the rate 
in 15 min and 30 min in low parity(14) but in 45 min in women with high 
parity.(15) this study the titration of oxytocin by increasing the rate every 
30 min, which is effective and of less complications. 
Studies show a wide range of effective dosage and changes 
intervals, and no regimen has been shown to be clearly superior.(14) 
In study of oxytocin dose found that the average dose was 10 
units, in this study the average dose is 6.5 units. 
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The dose of misoprostol in the literature by vaginal route range 
between 25-100 µg every 4-6 hours.(11) In this study the mean optimal 
dose was 59 µg. 
In comparison to literature the dose of PGE2 by vaginal route 
was 3-5 mg/ with the second dose, 6-8 hours, maximum dose 6 mg.(3) 
ln this study the dose was 3 mg, no additional dose was given, 
however, oxytocin was used additionally to 25% of the patients who 
received PGE2. 
In comparative study of misoprostol with oxytocin, they found 
that, the time of induction to the vaginal delivery in hours 10.6 hours 
and 14.8 hours, in this study the time of induction to delivery was 7.15, 
9.75 hours respectively, ^this shows decreases time of induction in this 
study. 
The duration of induction of labour in the literature, in 
comparative analysis of the three methods, misoprostol, oxytocin and 
PGE2 was 9, 11 and 10 hours respectively,(37) In comparison and 
contrast to this study the duration of induction of labour by these 
methods were 7.15, 8.3 and 9.75 hours respectively. The different of 
comparative duration showed that, time of induction of PGE2 was more 
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than oxytocin, in this study because we used PGE2 in unfavourable 
cervix and oxytocin when only the cervix was favourable. 
The vaginal delivery in this study using misoprostol, PGE2, 
oxytocin is [83.1%, 75% and 81% respectively] in comparable with 
Literature(36) vaginal delivery was successfully achieved in 85.7%, 
76.8%, 76.8% respectively, no significant difference between the three 
groups. 
The C/S in misoprostol, PGE2 and oxytocin is 17%, 16% and 
15% in this study, however, in the previous study 13.4%, 16.3% and 
8.2% respectively.(36) This different mainly due to 6 mg of PGE2 used in 
the previous study. 
In contrast to the literature, no significant difference following 
induction of labour by misoprostol, oxytocin and PGE2, in uterine 
hyperstimulation, however, in this study, there was significant 
difference in uterine hyperstimulation following induction of labour by 
misoprostol (9.5%) compared to induction by either oxytocin or PGE2 
(0%) and (0%) respectively. This in comparison with the literature may 
be due to that, misoprostol was used in a dose of 25 µg,(3) where these 
studies were found to compare with used 50 µg in the hospitals, where 
the study had been carried. Uterine hyperstimulation may be over 
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diagnose because it may be just tachysystole (increase uterine 
contractions with normal fetal heart). 
No significant difference in other maternal complications like, 
abruptio placentae, P.P.H, cord prolapse in this study compared to the 
literature.(1,5,33) 
The comparison of the literature to this study in foetal outcome, 
alive, fresh stillbirth, well cried immediately, resuscitated or admitted to 
the nursery, there was no significant different in the three methods of 
induction in form of foetal outcome. Misoprostol, oxytocin and PGE2 
alive baby, well cried immediately (89.9%), 85%, 90%, in form of fresh 
stillbirth, 0.5%. 0.6%. 0% respectively.  
In previous studied(3,11,27,33) concerning foetal outcome, there no 
significant difference with this study. 
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CONCLUSION 
 
• Intra-vaginal misoprostol and dinoprostone are safe and effective 
medications for use in cervical ripening and labour induction, 
misoprostol results in a shorter interval from induction to delivery, 
cheap and stable at room temperature. However, C/S due to   uterine   
hyperstimulation should be considered. 
•  Dinoprostone is expensive and needs refrigeration to maintain its 
potency. 
•  Oxytocin is a drug of choice in the patients with favourable cervix. 
•  There was no significant differences between misoprostol, PGE2 and 
oxytocin in the rate of C/S and foetal outcome. 
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RECOMMENDATIONS 
 
• Before starting induction of labour good assessment of the mother 
and her baby should be done. 
•  Induction of labour should be early in the morning to avoid night 
complications. 
•  Intrapartum foetal monitoring is the cornerstone in induction of 
labour. 
•  Any patient prepared for induction should be prepared for the 
possibility of an urgent C/S. 
•  The choice of the methods according to the cervix condition, oxytocin 
plus ARM in favourable cervix and misoprostol was a drug of choice 
in unfavourable cervix. 
•  Titration of oxytocin every 30 min in small dose in multiparae 
patients. 
•  Misoprostol intravaginally should be 25 µg every four hours to avoid 
uterine hyperstimulation. 
•  Protocols for induction of labour should be available in all hospitals. 
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